Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2

Molecular and Cellular Biology

Volumn 16, Issue 3, 1996, Pages 762-770

  Gorospe, Myriam ^a   Liu, Yusen ^a   Xu, Qingbo ^a   Chrest, Francis J ^a   Holbrook, Nikki J ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; PROSTAGLANDIN A2; REGULATOR PROTEIN; CDK4 PROTEIN, HUMAN; CDKN1A PROTEIN, HUMAN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1A; ONCOPROTEIN; PROSTAGLANDIN A; PROTEIN P53;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; BIOSYNTHESIS; BREAST TUMOR; CARCINOMA; CELL CULTURE; CELL DIVISION; DRUG EFFECT; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY;

MINK CELL FOCUS-FORMING VIRUS;

BREAST NEOPLASMS; CARCINOMA; CELL DIVISION; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ONCOGENE PROTEINS; PROSTAGLANDINS A; PROTO-ONCOGENE PROTEINS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029670838     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.3.762     Document Type: Article

References (56)

1. Amici, C., A. T. Palamara, and M. G. Santoro. 1993. Induction of thermotolerance by prostaglandin A in human cells. Exp. Cell Res. 207:230-234.
2. Choi, A. M., K. W. Tucker, S. G. Carlson, G. Weigand, and N. J. Holbrook. 1994. Calcium mediates expression of stress-response genes in prostaglandin A2-induced growth arrest. FASEB J. 8:1048-1054.
3. Church, G. M., and W. Gilbert. 1984. Genomic sequencing. Proc. Natl. Acad Sci. USA 81:1991-1995.
4. Cip1/Waf1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
5. Dulic, V., W. K. Kaufmann, S. J. Wilson, T. D. Tlsty, E. Lees, J. W. Harper, S. J. Elledge, and S. I. Reed. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013-1023.
6. el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF-1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
7. Ewen, M., H. K. Sluss, C. J. Sherr, H. Matsushime, J. Kato, and D. M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497.
8. 1 cell cycle arrest Genes Dev. 9:204-217.
9. Fan, S., M. L. Smith, D. J. Rivet, D. Duba, Q. Zhao, K. W. Kohn, A. J. Fornace, Jr., and P. M. O'Connor. 1995 Disruption of p53 function sensitizes breast cancer cells to cisplatin and pentoxifylline. Cancer Res. 55:1649-1654.
10. Fukushima, M., H. Sasaki, and S. Fukushima. 1994 Prostaglandin J2 and related compounds - mode of action in G1 arrest and preclinical results. Ann N. Y. Acad. Sci. 744:161-165.
11. INK4B MTS2-related CDK6 inhibitor, correlates with wild-type pRB function Genes Dev. 8:2939-2952.
12. Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD Science 267:1018-1021.
13. INK4B is a potential effector of TGF-β-induced cell cycle arrest Nature (London) 371:257-261.
14. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
15. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
16. Hengst, L., V. Dulic, J. M. Slingerland, E. Lees, and S. I. Reed. 1994. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA 91:5291-5295.
17. Hensey, C. E., F. Hong, T. Durfee, Y. W. Qian, E. Y. Lee, and W. H. Lee. 1994. Identification of discrete structural domains in the retinoblastoma protein. Amino-terminal domain is required for its oligomerization. J. Biol. Chem. 269:1380-1387.
18. 2: a growth-dependent response mediated by activation of heat shock transcription factor. Mol. Cell. Biol. 12:1528-1534.
19. Hughes-Fulford, M. 1994. Cell cycle arrest by prostaglandin A1 at the G1/S phase interface with up-regulation of oncogenes in S-49 cyc- cells. J. Cell Biochem. 54:265-272.
20. Jiang, H., J. Lin, Z. Su, F. R. Collart, E. Huberman, and P. Fisher. 1994. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21/WAF1/CIP1, expression in the absence of p53. Oncogene 9:3397-3406
21. Kikuchi, Y., T. Kita, J. Hirata, E. Kuki, I. Nagata, and M. Fukushima. 1992. Modulation of human lymphocyte response to phytohemagglutinin by antineoplastic prostaglandins. Int. J. Immunopharmacol. 14:105-110.
22. Kikuchi, Y., T. Kita, M. Miyauchi, J. Hirata, H. Sasa, I. Nagata, and M. Fukushima. 1992. Adjuvant effects of antineoplastic prostaglandins to cisplatin in nude mice bearing human ovarian cancer cells. J. Cancer Res. Clin. Oncol. 118:453-457.
23. cdc2 in T lymphocytes. J. Immunol. 149:17-23.
24. Koff, A., F. Cross, A. Fisher, J. Schumacher, C. Leguellec, M. Philippe, and J. M. Roberts. 1991. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 66:1217-1228.
25. Koff, A., A. Giordano, D. Desai, K. Yamashita, J. W. Harper, S. Elledge, T. Nishimoto, D. O. Morgan, B. R. Franza, and J. M. Roberts. 1992. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257:1689-1694.
26. LaThangue, N. B. 1994. DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell cycle control. Trends Biochem. Sci. 19:108-114
27. Lebwohl, D. E., R. Muise Helmericks, L. Sepp-Lorenzino, S. Serve, M. Timaul, R. Bol, P. Borgen, and N. Rosen. 1994. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line. Oncogene 9:1925-1929
28. Lee, M. H., I. Reynisdottir, and J. Massague. 1995 Cloning of p57(Kip2), a cyclin-dependent kinase inhibitor with unique domain-structure and tissue distribution. Genes Dev. 9:639-649.
29. Li, Y., C. W. Jenkins, M. A. Nichols, and Y. Xiong. 1994. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9:2261-2268
30. Lowe, S. W., H. E. Ruley, T. Jacks, and D. E. Housman. 1993. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967.
31. Lukas, J., D. Parry, L. Aagaard, D. J. Mann, J. Bartkova, M. Strauss, and J. Bartek. 1995. Retinoblastoma-protein-dependent cell cycle inhibition by the tumor suppressor p16. Nature (London) 375:503-506
32. Macleod, K. F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9:935-944.
33. Marui, N., T. Sakai, N. Hosokawa, M. Yoahida, A. Aoike, K. Kawai, H. Nishino, and M. Fukushima. 1990. N-myc suppression and cell cycle arrest at G1 phase by prostaglandins. FEBS Lett. 270:15-18.
34. Matsuoka, S., M. C. Edwards, C. Bai, S. Parker, P. M. Zhang, A. Baldini, J. W. Harper, and S. J. Elledge. 1995. p57(Kip2), a structurally distinct member of the p21(Cip1) cdk inhibitors family, is a candidate tumor suppressor gene Genes Dev. 9:650-662.
35. Michieli, P., M. Chedid, D. Lin, J. H. Pierce, W. E. Mercer, and D. Givol. 1994 Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54:3391-3395.
36. Morgan, D. O. 1995. Principles of CDK regulation. Nature (London) 374: 131-134.
37. Nevins, J. R. 1992. E2F, a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429.
38. Noda, A., Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res 211:90-98.
39. 2-induced growth inhibition. Biochem. Biophys. Res. Commun. 139:808-815.
40. Ohtsubo, M., and J. M. Roberts. 1993. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259:1908-1912.
41. 1-to-S phase transition. Mol. Cell Biol. 15:2612-2624.
42. Oswald, F., H. Lovec, T. Moroy, and M. Lipp. 1994. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions. Oncogene 9:2029-2036.
43. Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027
44. Polyak, K., M. H. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
45. Quelle, D. E., R. A. Ashmun, S. A. Shurtleff, J. Kato, D. Bar-Sagi, M. F. Roussel, and C. J. Sherr. 1993. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7:1559-1571.
46. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol 14:1669-1679
47. 1-to-S transition Mol. Cell. Biol. 15:3463-3469.
48. Sala, A., N. C. Nicolaides, A. Engelhard, T. Bellon, D. C. Lawe, A. Arnold, X. Grana, A. Giordano, and B. Calabretta. 1994. Correlation between E2F-1 requirement in the S phase and E2F-31 transactivation of cell-cycle related genes in human cells. Cancer Res 54:1402-1406.
49. Sasaki, H., and M. Fukushima. 1994. Prostaglandins in the treatment of cancer. Anticancer Drugs 5:131-138
50. 12-prostaglandin J2. Gynecol Oncol. 41:36-40
51. Sherr, C. J. 1995. D-type cyclins. Trends Biochem. Sci 20:187-190.
52. Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74.
53. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
54. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature (London) 366: 701-704.
55. Xiong, Y., H. Zhang, and D. Beach. 1992. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505-514.
56. Xiong, Y., H. Zhang, and D. Beach. 1993. Subunit rearrangement of cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7:1572-1583.